FDAnews
www.fdanews.com/articles/107731-hypertension-treatment-device-further-validated-in-new-studies

Hypertension Treatment Device Further Validated in New Studies

June 16, 2008
InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange, announced the findings of new studies and analysis highlighting RESPeRATE — the only medical device cleared by the FDA and CE-approved for the treatment of hypertension.
Yahoo! Finance